Neuropsychopharmacology
- Direct paraventricular thalamus-basolateral amygdala circuit modulates neuropathic pain and emotional anxiety2 years ago
- Anti-angiogenic mechanisms and serotonergic dysfunction in the Rgs2 knockout model for the study of psycho-obstetric risk2 years ago
- Physiological acetic acid concentrations from ethanol metabolism stimulate accumbens shell medium spiny neurons via NMDAR activation in a sex-dependent manner2 years ago
- Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial2 years ago
- Chemogenetic activation of CRF neurons as a model of chronic stress produces sex-specific physiological and behavioral effects2 years ago
- Antidepressants enter cells, organelles, and membranes2 years ago
- Correction: Digital and precision clinical trials: innovations for testing mental health medications, devices, and psychosocial treatments2 years ago
Journal of Psychopharmacology
- Development and validation of the Reward Deficiency Syndrome Questionnaire (RDSQ-29)3 years ago
- The neuropeptide cycloprolylglycine produces antidepressant-like effect and enhances BDNF gene expression in the mice cortex3 years ago
- Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study3 years ago
- Modulation of microglial activation by antidepressants3 years ago
- Refractory delirium tremens treated with ketamine4 years ago
- A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects4 years ago
- Incident infection during the first year of treatment – A comparison of clozapine and paliperidone palmitate long-acting injection4 years ago
European Neuropsychopharmacology
- New antidepressants: New day or false dawn?3 years ago
- Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism3 years ago
- Exposure to chronic stress impairs the ability to cope with an acute challenge: Modulation by lurasidone treatment3 years ago
- Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder3 years ago
- Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?3 years ago
- Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders3 years ago
- Cognitive impairment or dementia in post-acute COVID-19 syndrome. Two suspects and a perfect detective: positron emission tomography (PET) scan3 years ago